GlassScriptPhysician profile
Melody Cassels
NPI 1467664003
$1,420.54
in general payments reported to CMS, 2019-2025
22 companies · $338 in 2025
The $338 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.94 · 2020: $111 · 2021: $150 · 2022: $133 · 2023: $313 · 2024: $295 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $243.06 | 2021-2024 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $221.38 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $183.81 | 2023-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $132.47 | 2020-2025 | Vaxelis, Vaxneuvance, M-M-R II |
| Ironshore Pharmaceuticals INC. | $117.60 | 2023-2024 | Jornay Pm |
| Cranial Technologies, INC | $81.50 | 2019-2023 | Doc Band |
| Sanofi Pasteur INC. | $57.69 | 2020-2023 | |
| Collegium Pharmaceutical, INC. | $54.71 | 2025 | Jornay Pm |
| Lnhc, INC | $42.49 | 2025 | Zelsuvmi |
| Kowa Pharmaceuticals America, INC. | $32.79 | 2025 | Zoryve |
| Organon LLC | $32.35 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $30.90 | 2025 | Neffy |
| Pfizer INC. | $29.47 | 2022 | |
| Alk-Abello, INC | $23.58 | 2023 | Ragwitek, Odactra, Grastek |
| Glaxosmithkline, LLC. | $22.08 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.86 | 2023 | Id Now Instrument |
| Arbor Pharmaceuticals, INC. | $16.96 | 2019 | |
| Aytu Biopharma, INC. | $16.36 | 2024 | Karbinal |
| Corium, LLC | $15.50 | 2025 | Azstarys |
| Cepheid | $15.23 | 2025 | Genexpert |
| Travere Therapeutics, INC. | $14.54 | 2023 | Cholbam |
| Mirum Pharmaceuticals, INC. | $14.21 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Cassels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.